Health and Happiness (H&H) International Holdings Limited (BTSDF)
BTSDF Stock Price Chart
Explore Health and Happiness (H&H) International Holdings Limited interactive price chart. Choose custom timeframes to analyze BTSDF price movements and trends.
BTSDF Company Profile
Discover essential business fundamentals and corporate details for Health and Happiness (H&H) International Holdings Limited (BTSDF) to support your stock research and investment decisions.
Sector
Consumer Defensive
Industry
Packaged Foods
IPO Date
21 Apr 2011
Employees
2.80K
Website
https://www.hh.globalCEO
Akash Bedi
Description
Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products worldwide. The company's Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. Its Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The company's Adult Nutrition and Care Products segment produces vitamins, health supplements, and skincare and sports nutrition products for adults. Its Other Pediatric Products segment produces dried baby food and nutrition supplements, and baby care products. The company's Pet Nutrition and Care products segment produces food, health supplements, and bone broth products for pets. It is also involved in the research, development, and processing of meat, fruit, and vegetable powder and candy; research, development, manufacture, and sale of special nutritional foods; marketing and distribution of organic baby foods; and wholesale, retail, import, and export of nutritional food and personal care products for infants. In addition, the company engages in the trading and sale of vitamins, health supplements, probiotic skin care, and sports nutrition products for adults; and provision of online sales, software, and information technology services, as well as packaging services. It provides its products under the Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII brands. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.
BTSDF Financial Timeline
Browse a chronological timeline of Health and Happiness (H&H) International Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Mar 2026
Dividend declared on 9 Sept 2025
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend will be paid on 17 Oct 2025.
Earnings released on 26 Aug 2025
EPS came in at $0.08 , while revenue for the quarter reached $979.53M .
Dividend declared on 26 Aug 2025
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend will be paid on 17 Oct 2025.
Earnings released on 25 Mar 2025
EPS came in at -$0.56 , while revenue for the quarter reached $6.36B .
Dividend declared on 25 Mar 2025
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 9 Jul 2025.
Earnings released on 27 Aug 2024
EPS came in at $0.48 surpassing the estimated $0.06 by +743.26%, while revenue for the quarter reached $6.69B , beating expectations by +635.88%.
Dividend declared on 27 Aug 2024
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 15 Oct 2024.
Earnings released on 17 May 2024
EPS came in at -$0.04 falling short of the estimated $0.02 by -307.15%, while revenue for the quarter reached $6.95B , beating expectations by +623.90%.
Dividend declared on 26 Mar 2024
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 10 Jul 2024.
Dividend declared on 22 Aug 2023
A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 10 Oct 2023.
Earnings released on 30 Jun 2023
EPS came in at $0.95 surpassing the estimated $0.10 by +879.27%, while revenue for the quarter reached $6.98B , beating expectations by +685.40%.
Dividend declared on 21 Mar 2023
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 11 Jul 2023.
Earnings released on 31 Dec 2022
EPS came in at $0.21 surpassing the estimated $0.09 by +148.07%, while revenue for the quarter reached $6.82B , beating expectations by +587.04%.
Dividend declared on 9 Sept 2022
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 13 Oct 2022.
Earnings released on 29 Aug 2022
EPS came in at $0.11 surpassing the estimated $0.11 by +4.10%, while revenue for the quarter reached $888.72M , missing expectations by -3.35%.
Dividend declared on 29 Aug 2022
A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 13 Oct 2022.
Dividend declared on 22 Mar 2022
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 12 Jul 2022.
Earnings released on 31 Dec 2021
EPS came in at $0.39 surpassing the estimated $0.12 by +229.26%, while revenue for the quarter reached $5.77B , beating expectations by +516.40%.
Dividend declared on 24 Aug 2021
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 12 Oct 2021.
Earnings released on 30 Jun 2021
EPS came in at $0.39 surpassing the estimated $0.11 by +253.50%, while revenue for the quarter reached $5.77B , beating expectations by +592.19%.
Dividend declared on 23 Mar 2021
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 13 Jul 2021.
Dividend declared on 23 Mar 2021
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend was paid on 13 Jul 2021.
Earnings released on 31 Dec 2020
EPS came in at $0.88 surpassing the estimated $0.09 by +926.51%, while revenue for the quarter reached $5.60B , beating expectations by +504.80%.
BTSDF Stock Performance
Access detailed BTSDF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.